Week 28 - Jul 7-13, 2025

📢 Industry Highlights in Biotech & Life Sciences 📢

From leadership changes to licensing deals and product launches, here's a roundup of recent developments shaping the future of healthcare innovation:

Sources

🔗 Biocytogen Enters into Antibody Licensing Agreement with BeOne Medicines to Accelerate Innovative Drug Development

🔗 Radiant Biotherapeutics Appoints Deborah Geraghty, Ph.D., as President and Chief Executive Officer

🔗 enGene Announces Board and Leadership Appointments to Support Commercial Readiness

🔗 OTC Markets Group Welcomes Vaxart, Inc. to OTCQX

🔗 UAE Approves BioAro’s Longevity+ Supplement, Signaling Major Market Potential in Global Preventive Health

🔗 Invivoscribe Expands Flow Cytometry Services to Accelerate CAR-T Immunotherapy Development and Regulatory Readiness

🔗 ImmunoPrecise Antibodies Appoints Industry Veteran Jon Lieber to Board of Directors

🔗 Life Sciences BC Announces 2025 Awards Winners, Honouring Excellence in Health Innovation

🔗 Newly Elected Directors of Sinovac Hold the First Board Meeting

#biotech #lifesciences #healthcareinnovation #leadership #drugdevelopment #clinicaltrials #biopharma #LinkedInNews

💡 Follow the BioTech Weekly newsletter for more updates on biotech breakthroughs, regulatory milestones, and investment trends in life sciences.

Disclaimer: This podcast includes content generated with the help of large language models (LLM). Although care has been taken to ensure accuracy, LLMs can sometimes produce incorrect or misleading information. Listeners are advised to independently verify any details, provide feedback, and reach out.